INS and type 2 diabetes mellitus: For example, in Goto-Kakizaki (GK) rats—a well-established type 2 diabetes model—berberine treatment increased β-cell number and induced morphological improvements, such as larger and more rounded nuclei, ameliorating pancreatic pathology, which were associated with reduced fasting blood glucose and improved insulin sensitivity [153].